Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Philadelphia reinstates face-mask mandate for students and teachers, and WHO head warns pandemic is ‘most certainly not over’
11:56am, Tuesday, 24'th May 2022 MarketWatch
Philadelphia has reinstated a face-mask mandate for students and teachers that comes into effect Monday, in its latest move to rein in COVID-19 infections.
‘If you wait for the right time to travel you may never do it’ — seniors take stock of risks as COVID cases rise
10:03am, Tuesday, 24'th May 2022 MarketWatch
How retirees can travel safely this summer
Why Moderna and Pfizer Stocks Lagged the Market Today
09:05pm, Monday, 23'rd May 2022 The Motley Fool
Despite good regulatory news for both companies, and encouraging clinical results reported from one, investor reaction was muted.
The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma
06:44pm, Monday, 23'rd May 2022 Benzinga
Concert Pharmaceuticals Inc (NASDAQ: CNCE) has released highly positive Phase 3 data for their alopecia areata drug CTP-543 from the THRIVE-AA1 trial.
Mizuho says that the efficacy supports its v
Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch
04:31pm, Monday, 23'rd May 2022 Benzinga
The Direxion Daily Healthcare Bull 3X Shares (NYSE: CURE) gapped up almost 2.52% higher on Monday in response to outbreaks of monkeypox being reported in several western nations.
CURE is a triple leve
3 Monkeypox Stocks That Soared Last Week
09:13am, Monday, 23'rd May 2022 The Motley Fool
Fear of another viral outbreak is generating a lot of buzz around these three biotech stocks.
‘I chose to take a gamble’: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatment
11:28pm, Sunday, 22'nd May 2022 MarketWatch
The plot unraveled after Chenyan Wu was caught trying to sneak toxic chemicals into the U.S. from China to start a lab in San Diego.
Biotech is in ‘a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
12:10pm, Sunday, 22'nd May 2022 MarketWatch
Watch for these 3 catalysts and consider these 6 stocks.
Have $2,000? 2 Market Crash-Ready Stocks to Buy
10:00am, Sunday, 22'nd May 2022 The Motley Fool
These stocks have great long-term prospects.
Mystery Solved! The Top 9 Bestselling Products In History
08:10pm, Friday, 20'th May 2022 Benzinga
The bestselling products in the world stand at the crossroads of innovation meets the ability to formulate a product that has never been made before.
For example, the Rubik’s Cube. This innovative
Why Pfizer Stock Is Rising Today While Moderna and Novavax Are Sliding
04:01pm, Friday, 20'th May 2022 The Motley Fool
Different dynamics are at work for these vaccine stocks.
COVID-19 boosters for children to be rolled out
03:45pm, Friday, 20'th May 2022 MarketWatch
The CDC allows a COVID-19 booster for children, vaccination may lessen long COVID symptoms and the U.S. reports another 100,000 cases
U.S. government is offering free COVID tests again, as cases rise 57% from two weeks ago; FDA authorizes booster for children aged 5 to 11
01:44pm, Friday, 20'th May 2022 MarketWatch
The federal government is again offering Americans free COVID-19 test kits through the mail, allowing for up to eight more tests to be ordered through the USPS.
Pharma Stock Roundup: FDA Nod to PFE COVID Jab for Age 5-11 & LLY's Tirzepatide
12:50pm, Friday, 20'th May 2022 Zacks Investment Research
FDA grants emergency approval to Pfizer's COVID-19 vaccine for use in children 5- to 11-year old and approves Lilly's (LLY) novel diabetes treatment, Mounjaro (tirzepatide).
CDC advisers recommend Pfizer COVID-19 booster shot for kids ages 5 to 11
08:25pm, Thursday, 19'th May 2022 MarketWatch
Experts advising the CDC on vaccines recommended that children age 5 to 11 receive the newly authorized COVID booster shot from Pfizer Inc. and BioNTech SE.
